Archive · 2 Oct 2025
Indegene Acquires BioPharm to Enhance AI-Driven Pharma Marketing
Indegene, a tech company, is buying BioPharm, a marketing agency, for $106 million.
BioPharm helps drug companies market their products.
This deal will help Indegene make its marketing smarter using AI.
BioPharm has a lot of clients, including many of the biggest drug companies.
The goal is to help these companies reach doctors better and sell more drugs.
The healthcare industry is changing, and companies like Indegene are helping drug companies adapt to these changes by using new technologies.
Indegene acquired BioPharm for $106 million.
BioPharm is a marketing services agency focused on life sciences.
The acquisition aims to enhance Indegene's AI-powered marketing.
BioPharm reported $38.13 million in revenue in 2024.
BioPharm serves 17 of the top 25 global biopharma companies.
- Who
- Indegene acquired BioPharm.
- What
- Indegene acquired BioPharm to boost its AI-powered pharma marketing.
- When
- The acquisition was recently announced.
- Where
- BioPharm is based in Pennsylvania, USA.
- Why
- To strengthen Indegene's commercialization portfolio and expand its AI-powered marketing capabilities.
- Acquisition Target
- BioPharm
- Acquirer
- Indegene
- Acquisition Price
- $106 million
- BioPharm Revenue (2024)
- $38.13 million
- BioPharm Employees
- 90+
- BioPharm Clients
- 17 of top 25 biopharma companies